You must log in to view this page.

Halozyme Therapeutics Inc.

NASDAQ: HALO
Share price (8/12/25): $64.04
Market cap (8/12/25): $7.491 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

EX-1.1

from 8-K 30 pages Halozyme Therapeutics, Inc. 10,000,000 Shares of Common Stock, Par Value $0.001 Per Share Underwriting Agreement

12/34/56

EX-1.1

from 8-K 36 pages Halozyme Therapeutics, Inc. 7,692,307 Shares of Common Stock, Par Value $0.001 Per Share Underwriting Agreement

12/34/56

EX-1

from SC 13D/A 1 page Joint Filing Agreement

12/34/56

EX-1

from SC 13D/A 1 page Joint Filing Agreement

12/34/56

EX-1.1

from 8-K 31 pages 6,800,000 Shares Halozyme Therapeutics, Inc. Common Stock ($0.001 Par Value) Underwriting Agreement

12/34/56

EX-1

from SC 13D/A 1 page Joint Filing Agreement

12/34/56

EX-1.1

from 8-K ~20 pages 8,300,000 Shares Halozyme Therapeutics, Inc. Common Stock ($0.001 Par Value) Underwriting Agreement

12/34/56

EX-1.1

from 8-K 30 pages 6,150,000 Shares Halozyme Therapeutics, Inc. Common Stock ($.001 Par Value) Underwriting Agreement

12/34/56

Halozyme Therapeutics Inc. Watch

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

Halozyme Therapeutics Inc.